Philip C Robinson1, William J Taylor. 1. Rheumatology Department, Hutt Hospital, Wellington, New Zealand. philip.c.robinson@gmail.com
Abstract
BACKGROUND: The importance of early diagnosis and treatment of rheumatoid arthritis (RA) is increasingly being recognized. This requires accurate triaging of suspected RA referrals from primary care and expedient assessment of these patients in secondary care. OBJECTIVES: To assess the factors associated with urgent triage for first specialist appointment and early disease modifying agents in rheumatic disease treatment. METHODS: The general practitioner (GP) referrals to a single rheumatology service from 128 new RA patients were assessed for their information content and triage allocation by the Rheumatologists. Information on symptoms, signs, and investigation results were collected. Factors associated with urgent triage allocation, time to treatment, and a GP requesting urgency were assessed. RESULTS: Median time from symptom onset to treatment was 6.1 months. Triage allocation to urgent was associated with earlier treatment (difference of 97 days, P = 0.003). GP perception of urgency (odds ratio = 13.34, 95% confidence interval: 2.20-81.02) was independently associated with an urgent triage allocation by the triaging rheumatologist. Swollen joints and a raised C-reactive protein predicted GP request for urgency. CONCLUSION: Triage is important to facilitate early treatment; however, rheumatologists in this service are not currently triaging suspected RA referrals with reference to known poor prognostic indicators. Several interventions could improve both informative referrals and triaging of referrals to decrease time to diagnosis and treatment. These interventions could include public education, GP education sessions with associated distribution of referral guidelines, and reminding triaging rheumatology clinicians about the available prognostic factors often present in GP referrals that assist with correct triage.
BACKGROUND: The importance of early diagnosis and treatment of rheumatoid arthritis (RA) is increasingly being recognized. This requires accurate triaging of suspected RA referrals from primary care and expedient assessment of these patients in secondary care. OBJECTIVES: To assess the factors associated with urgent triage for first specialist appointment and early disease modifying agents in rheumatic disease treatment. METHODS: The general practitioner (GP) referrals to a single rheumatology service from 128 new RApatients were assessed for their information content and triage allocation by the Rheumatologists. Information on symptoms, signs, and investigation results were collected. Factors associated with urgent triage allocation, time to treatment, and a GP requesting urgency were assessed. RESULTS: Median time from symptom onset to treatment was 6.1 months. Triage allocation to urgent was associated with earlier treatment (difference of 97 days, P = 0.003). GP perception of urgency (odds ratio = 13.34, 95% confidence interval: 2.20-81.02) was independently associated with an urgent triage allocation by the triaging rheumatologist. Swollen joints and a raised C-reactive protein predicted GP request for urgency. CONCLUSION: Triage is important to facilitate early treatment; however, rheumatologists in this service are not currently triaging suspected RA referrals with reference to known poor prognostic indicators. Several interventions could improve both informative referrals and triaging of referrals to decrease time to diagnosis and treatment. These interventions could include public education, GP education sessions with associated distribution of referral guidelines, and reminding triaging rheumatology clinicians about the available prognostic factors often present in GP referrals that assist with correct triage.
Authors: José Andrés Román Ivorra; Juan Antonio Martínez; Pablo Lázaro; Federico Navarro; Antonio Fernandez-Nebro; Eugenio de Miguel; Estibaliz Loza; Loreto Carmona Journal: Rheumatol Int Date: 2013-04-09 Impact factor: 2.631
Authors: Louise C Pollard; Helen Graves; David L Scott; Gabrielle H Kingsley; Heidi Lempp Journal: BMC Musculoskelet Disord Date: 2011-01-17 Impact factor: 2.362
Authors: Rebecca J Stack; Zara Llewellyn; Chris Deighton; Patrick Kiely; Christian D Mallen; Karim Raza Journal: Scand J Prim Health Care Date: 2014-03 Impact factor: 2.581
Authors: Alaa S Barhamain; Rami F Magliah; Mohammad H Shaheen; Shurooq F Munassar; Ayman M Falemban; Mohammed M Alshareef; Hani M Almoallim Journal: Open Access Rheumatol Date: 2017-07-28
Authors: Rudolf Puchner; Michael Edlinger; Erich Mur; Gabriele Eberl; Manfred Herold; Peter Kufner; Antonia Puchner; Stephan E Puchner; Kurt Redlich; Alois Alkin; Klaus Machold Journal: PLoS One Date: 2016-01-07 Impact factor: 3.240